Harish Shantharam Cyma Bay Therapeutics, Inc. (CBAY) insider trading activity

CBAY Quotes by TradingView

Harish Shantharam is Chief Financial Officer of CymaBay Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CBAY, which is worth approximately $0. The most recent transaction as insider was on Mar 22, 2024, when has been sold 20,125 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Harish Shantharam Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 22 2024
SELL
Sale (or disposition) back to the issuer
-
20,125 Reduced 100.0%
0 Common Stock
Jan 24 2024
BUY
Grant, award, or other acquisition
-
20,125 Added 50.0%
20,125 Common Stock
HS

Harish Shantharam

Chief Financial Officer
Newark, CA

Track Institutional and Insider Activities on CBAY

Follow CymaBay Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CBAY shares.

Notify only if

Insider Trading

Get notified when an Cyma Bay Therapeutics, Inc. insider buys or sells CBAY shares.

Notify only if

News

Receive news related to CymaBay Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CBAY